| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.98▼ | 4.96▲ | 4.96▲ | 4.70▲ | 4.51▲ |
| MA10 | 4.98▼ | 4.96▲ | 4.89▲ | 4.56▲ | 4.68▲ |
| MA20 | 4.97▲ | 4.87▲ | 4.77▲ | 4.46▲ | 5.08▼ |
| MA50 | 4.96▲ | 4.72▲ | 4.59▲ | 4.75▲ | 4.06▲ |
| MA100 | 4.89▲ | 4.59▲ | 4.49▲ | 5.05▼ | 3.66▲ |
| MA200 | 4.78▲ | 4.49▲ | 4.45▲ | 4.17▲ | 3.80▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.000▼ | 0.017▲ | 0.087▲ | -0.126▼ |
| RSI | 51.841▲ | 72.798▲ | 74.951▲ | 64.870▲ | 54.700▲ |
| STOCH | 42.940 | 49.268 | 78.388 | 81.465▲ | 26.165 |
| WILL %R | -66.667 | -21.212▲ | -16.867▲ | -6.832▲ | -58.185 |
| CCI | 1.389 | 51.759 | 72.170 | 241.101▲ | -21.721 |
|
Friday, June 26, 2026 03:17 PM
Atea Pharmaceuticals (NASDAQ:AVIR) draws attention after a fresh news hook tied to patient enrollment milestone, with sector context and market relevance.
|
|
Thursday, June 25, 2026 04:20 AM
End 2026 More Than 880 HCV Treatment-Naïve Patients Enrolled Across 17 Countries Outside North America C-FORWARD and C-BEYOND Represent the First Global Phase 3 Head-to-Head Trials of Direct-Acting ...
|
|
Tuesday, June 16, 2026 08:34 PM
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at AAR (NYSE:AIR) and the best and worst ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/07/26 | 4.888 | 5.035 | 4.78 | 4.98 | 415,098 |
| 01/07/26 | 4.68 | 4.78 | 4.625 | 4.78 | 472,559 |
| 30/06/26 | 4.61 | 4.68 | 4.55 | 4.65 | 327,532 |
| 29/06/26 | 4.50 | 4.63 | 4.38 | 4.61 | 320,355 |
| 26/06/26 | 4.35 | 4.52 | 4.34 | 4.49 | 1,132,851 |
| 25/06/26 | 4.49 | 4.56 | 4.30 | 4.35 | 234,140 |
| 24/06/26 | 4.48 | 4.58 | 4.425 | 4.48 | 311,330 |
| 23/06/26 | 4.37 | 4.555 | 4.37 | 4.48 | 192,753 |
| 22/06/26 | 4.37 | 4.48 | 4.32 | 4.39 | 343,922 |
| 18/06/26 | 4.40 | 4.46 | 4.24 | 4.36 | 592,537 |
|
|
||||
|
|
||||
|
|